ENSYSCE BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -6.90% for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-06-08.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2021-06-08
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was -6.90%.
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2019 was -1.20%.
- ENSYSCE BIOSCIENCES, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2020-12-31 | -6.90% 10-K/A · filed 2021-06-08 | -11.80% 10-K · filed 2021-03-15 |
| 2019-12-31 | -1.20% 10-K/A · filed 2021-06-08 | 0.70% 10-K · filed 2020-03-10 |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |